JANX - Janux Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.57
DETAILS
HIGH:
$45.00
LOW:
$14.00
MEDIAN:
$30.00
CONSENSUS:
$28.57
UPSIDE:
96.76%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 10 | 10.6 | 8.1 | 8.6 | 3.6 | 0 | 0 |
| Cost of Revenue | 2.0 | 2.1 | 2.0 | 0.8 | 0 | 0.0 | 0.0 |
| Gross Profit | 8.0 | 8.5 | 6.1 | 7.8 | 3.6 | (0.0) | (0.0) |
| Operating Expenses | |||||||
| R&D Expenses | 125.9 | 68.4 | 54.9 | 53.4 | 26.2 | 3.0 | 3.0 |
| SG&A Expenses | 41.8 | 41.0 | 26.1 | 22.3 | 10.3 | 1.8 | 0.8 |
| Other Expenses | (2.0) | (2.1) | (2.0) | (0.8) | 0 | 0 | 0 |
| Operating Expenses | 165.6 | 107.4 | 79.1 | 74.9 | 36.6 | 4.8 | 3.8 |
| Operating Income | |||||||
| Operating Income | (157.7) | (98.8) | (73.0) | (67.1) | (32.9) | (4.8) | (3.8) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.2 |
| Interest Income | 44.0 | 29.9 | 14.7 | 4.0 | 0.3 | 0.2 | 0.2 |
| Profitability | |||||||
| EBITDA | (111.6) | (96.8) | (71.0) | (66.2) | (32.8) | (6.6) | (3.8) |
| EBIT | (113.6) | (98.8) | (73.0) | (67.1) | (32.9) | (6.6) | (3.8) |
| Income Before Tax | (113.6) | (69.0) | (58.3) | (63.1) | (32.7) | (6.8) | (4.0) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (113.6) | (69.0) | (58.3) | (63.1) | (32.7) | (6.8) | (4.2) |
| Per Share Data | |||||||
| EPS (Basic) | -1.83 | -1.28 | -1.32 | -1.52 | -0.79 | -0.16 | -0.10 |
| EPS (Diluted) | -1.83 | -1.28 | -1.32 | -1.52 | -0.79 | -0.16 | -0.10 |
| Shares Outstanding | 62.0 | 53.8 | 44.0 | 41.5 | 41.2 | 41.6 | 41.6 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 52.3 | 430.6 | 19.2 | 51.4 | 35.6 | 7.8 | 0.7 |
| Short-Term Investments | 914.2 | 594.6 | 324.8 | 275.6 | 339.4 | 0 | 0 |
| Net Receivables | 6.4 | 5.4 | 0 | 0.7 | 0 | 8 | 0 |
| Inventory | 0 | 0 | 0 | (0.7) | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 5.2 | 5.4 | 0 | 0 | 0 |
| Total Current Assets | 975.9 | 1,033.7 | 349.2 | 332.4 | 377.0 | 16.1 | 0.7 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 22.3 | 24.1 | 27.8 | 29.4 | 1.6 | 0.2 | 0.0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0.8 | 0 | 0 | 0.8 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.6 | 3.7 | 3.3 | 1.4 | 1.2 | 0 | 0 |
| Total Non-Current Assets | 31.6 | 27.9 | 31.2 | 31.6 | 2.8 | 0.2 | 0.0 |
| Total Assets | 1,007.5 | 1,061.5 | 380.4 | 364.0 | 379.8 | 16.2 | 0.7 |
| Current Liabilities | |||||||
| Account Payables | 5.0 | 4.0 | 2.4 | 2.2 | 2.5 | 0.4 | 0.3 |
| Short-Term Debt | 2.4 | 0 | 0 | 0 | 0 | 0 | 4 |
| Deferred Revenue | 0 | 0 | 1.7 | 5.4 | 5.2 | 1.9 | 0 |
| Other Current Liabilities | 13.0 | 11.7 | 3.3 | 5.5 | 2.4 | 0.3 | 0.1 |
| Total Current Liabilities | 25.0 | 17.5 | 13.0 | 16.5 | 12.8 | 3.2 | 4.6 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 6.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 21.6 | 4.0 |
| Total Non-Current Liabilities | 25.7 | 21.3 | 23.0 | 26.8 | 0.7 | 27.7 | 4.0 |
| Total Liabilities | 50.7 | 38.7 | 36.1 | 43.3 | 13.5 | 30.9 | 8.6 |
| Stockholders' Equity | |||||||
| Common Stock | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (351.4) | (237.8) | (168.8) | (110.5) | (47.4) | (14.7) | (8.0) |
| Accumulated Other Comprehensive Income | 4.3 | 2.2 | 0.7 | (1.5) | (0.3) | 0 | 0 |
| Total Stockholders' Equity | 956.8 | 1,022.8 | 344.3 | 320.7 | 366.3 | (14.6) | (7.9) |
| Total Liabilities & Equity | 1,007.5 | 1,061.5 | 380.4 | 364.0 | 379.8 | 16.2 | 0.7 |
| Debt Metrics | |||||||
| Total Debt | 22.1 | 23.0 | 24.5 | 25.3 | 0.2 | 0 | 4 |
| Net Debt | (30.2) | (407.6) | 5.3 | (26.1) | (35.4) | (7.8) | 3.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (113.6) | (69.0) | (58.3) | (63.1) | (32.7) | (6.8) | (4.0) |
| Depreciation & Amortization | 2.0 | 2.1 | 2.0 | 0.8 | 0.1 | 0.0 | 0.0 |
| Stock-Based Compensation | 40.2 | 33.0 | 20.0 | 17.2 | 6.9 | 0.1 | 0.0 |
| Change in Working Capital | 6.7 | 0.7 | (6.6) | 4.3 | 8.8 | 0.4 | (0.1) |
| Other Non-Cash Items | (17.6) | (10.6) | (7.7) | (2.2) | (0.2) | 1.9 | 0.2 |
| Operating Cash Flow | (82.2) | (43.8) | (50.6) | (42.9) | (17.0) | (4.4) | (3.8) |
| Investing Activities | |||||||
| Capital Expenditure | (1.0) | (0.4) | (1.9) | (6.4) | (1.5) | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | (64.7) | 339.5 | 0 | 0 |
| Purchases of Investments | (705.2) | (470.6) | (317.3) | (294.4) | (473.6) | 0 | 0 |
| Sales/Maturities of Investments | 405.3 | 212.9 | 278 | 359.1 | 134.1 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 64.7 | (339.5) | 0 | 0 |
| Investing Cash Flow | (301.0) | (258.0) | (41.2) | 58.3 | (341.0) | 0 | 0 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 2.5 | 4 |
| Stock Repurchased | (0.3) | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 15.0 | 3.0 | 0 | 1.8 | 0.1 | 0 |
| Financing Cash Flow | 4.9 | 713.2 | 59.5 | 0.5 | 386.5 | 11.5 | 4 |
| Cash Position | |||||||
| Net Change in Cash | (378.3) | 411.4 | (32.2) | 15.8 | 28.6 | 7.2 | 0.2 |
| Cash at Beginning | 431.4 | 20.0 | 52.2 | 36.4 | 7.8 | 0.7 | 0.5 |
| Cash at End | 53.1 | 431.4 | 20.0 | 52.2 | 36.4 | 7.8 | 0.7 |
| Free Cash Flow | (83.3) | (44.2) | (52.4) | (49.4) | (18.5) | (4.4) | (3.8) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 10 | 10.6 | 8.1 | 8.6 | 3.6 | 0 | 0 |
| Gross Profit | 8.0 | 8.5 | 6.1 | 7.8 | 3.6 | (0.0) | (0.0) |
| Operating Income | (157.7) | (98.8) | (73.0) | (67.1) | (32.9) | (4.8) | (3.8) |
| Net Income | (113.6) | (69.0) | (58.3) | (63.1) | (32.7) | (6.8) | (4.2) |
| EPS (Diluted) | -1.83 | -1.28 | -1.32 | -1.52 | -0.79 | -0.16 | -0.10 |
| Balance Sheet | |||||||
| Cash & Equivalents | 52.3 | 430.6 | 19.2 | 51.4 | 35.6 | 7.8 | 0.7 |
| Total Assets | 1,007.5 | 1,061.5 | 380.4 | 364.0 | 379.8 | 16.2 | 0.7 |
| Total Debt | 22.1 | 23.0 | 24.5 | 25.3 | 0.2 | 0 | 4 |
| Stockholders' Equity | 956.8 | 1,022.8 | 344.3 | 320.7 | 366.3 | (14.6) | (7.9) |
| Cash Flow | |||||||
| Operating Cash Flow | (82.2) | (43.8) | (50.6) | (42.9) | (17.0) | (4.4) | (3.8) |
| Capital Expenditure | (1.0) | (0.4) | (1.9) | (6.4) | (1.5) | 0 | 0 |
| Free Cash Flow | (83.3) | (44.2) | (52.4) | (49.4) | (18.5) | (4.4) | (3.8) |